Google Alert - hepatitis c

[Guest guest]

News

10 new results for hepatitis c

New Drug May Boost Hepatitis C TreatmentBusinessWeekBy Reinberg WEDNESDAY, March 30 (HealthDay News) -- Adding the new drug boceprevir to the current two-drug treatment for hepatitis C appears significantly more effective than the standard therapy, according to two new studies. ...See all stories on this topic »

Vertex Pharma's Telaprevir Improves Viral Cure Rates In Hepatitis CRTT News(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX: News ), said Thursday its Telaprevir-based therapy significantly improved viral cure rates in Hepatitis C patients whose prior treatment with pegylated-interferon and ribavirin was unsuccessful. ...See all stories on this topic »

REG-Novartis first-in-class antiviral DEB025 achieved sustained viral response ...Reuters (press release)The study involved nearly 300 previously untreated patients infected with the most common form of hepatitis C virus (HCV), the genotype 1 (G1)[1]. The data were presented today at the European Association for the Study of the Liver (EASL) congress in ...See all stories on this topic »

Fluvastatin Enhances Chronic Hepatitis C Treatment Response in Combination ...PR Newswire UK (press release)New data presented today at the International Liver Congress confirm the antiviral activity of fluvastatin - commonly used as a cholesterol-lowering treatment - in patients with chronic hepatitis C (HCV).[1] Patients had improved early and ...See all stories on this topic »

Hope for liver patientsWorcester TelegramBy Nugent TELEGRAM & GAZETTE STAFF Dr. Heidi L. of the University of Massachusetts Medical School is performing trials for a new hepatitis C antibody. (T & G Staff/TOM RETTIG) WORCESTER — A new liver does not mean the end of hepatitis C. The ...See all stories on this topic »

Vertex Pharmaceuticals' potential hepatitis C treatment meets safety goal in ...CanadianBusiness.com(AP) - Vertex Pharmaceuticals Inc. said Thursday that a potential hepatitis C treatment was safe and tolerable in a midstage study. The study involved a combination of telaprevir and VX-222 with pegylated-interferon and ribavirin and focused on people ...See all stories on this topic »

Dual Drug Therapy Assures Effective Treatment of Hepatitis CTopNews New ZealandA breakthrough study has been made in the field of hepatitis C virus. As per the study, a combined therapy of two drugs namely boceprevir and telaprevir can prove to be highly effective for the patients of hepatitis C virus. ...See all stories on this topic »

TopNews New Zealand

OctoPlus' licensee Biolex presents Phase IIb results at EASL showing reduced ...Reuters (press release)In combination with its reduced injection frequency, these benefits clearly position Locteron as the interferon of choice for future hepatitis C treatments." The following information was taken directly from Biolex' press release (see www.biolex.com). ...See all stories on this topic »

Adverse event profile of regimen containing BMS-790052 was consistent with ...Benzinga“There currently exists a medical need for new medicines or new combinations of medicines for hepatitis C patients as many hepatitis C patients have limited success on the currently available treatments,†said Stanislas Pol, MD, PhD, Professor of ...See all stories on this topic »

NEJM publishes MSD's VICTRELIS two pivotal Phase III studies against HCVNews-Medical.netMSD (NYSE: MRK), known as Merck in the United States and Canada, announced today that final results from the two pivotal Phase III studies of VICTRELIS ™ (boceprevir), its investigational oral hepatitis C protease inhibitor, will be published in the ...See all stories on this topic »